{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:55:44Z","timestamp":1792155344125,"version":"4.4.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["R01HD062844"],"award-info":[{"award-number":["R01HD062844"]}]},{"name":"National Institute of Health","award":["R33AI079740"],"award-info":[{"award-number":["R33AI079740"]}]},{"name":"National Institute of Health","award":["R01EB015031"],"award-info":[{"award-number":["R01EB015031"]}]},{"name":"Johns Hopkins University Center for AIDS Research","award":["1P30AI094189"],"award-info":[{"award-number":["1P30AI094189"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jconrel.2014.04.033","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T08:49:25Z","timestamp":1400057365000},"page":"500-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"special_numbering":"C","title":["Nanoparticle-based drug delivery to the vagina: A review"],"prefix":"10.1016","volume":"190","author":[{"given":"Laura M.","family":"Ensign","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.04.033_bb0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12249-008-9073-5","article-title":"A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV\/AIDS and prevention of sexually transmitted infections","volume":"9","author":"Ndesendo","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0010","first-page":"1","article-title":"A review on vaginal route as a systemic drug delivery","volume":"1","author":"Ashok","year":"2012","journal-title":"Crit. Rev. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1461-5347(98)00104-7","article-title":"Vaginal microbicide formulations workshop","volume":"1","author":"Garg","year":"1998","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/00016346409162686","article-title":"Intracavitary circulation of aqueous material in the human vagina","volume":"43","author":"Odeblad","year":"1964","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000070184","article-title":"Surface area of the human vagina as measured from vinyl polysiloxane casts","volume":"55","author":"Pendergrass","year":"2003","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2004.06.013","article-title":"In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse","volume":"70","author":"Barnhart","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/aid.2011.0071","article-title":"A comparison of lower genital tract glycogen and lactic acid levels in women and macaques: implications for HIV and SIV susceptibility","volume":"28","author":"Mirmonsef","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0045","series-title":"Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy","author":"Sande","year":"1999"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0050","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1128\/IAI.67.10.5170-5175.1999","article-title":"Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification","volume":"67","author":"Boskey","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/jrf.0.0330069","article-title":"Continuous measurement by radio-telemetry of vaginal pH during human coitus","volume":"33","author":"Fox","year":"1973","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00016346809156845","article-title":"The functional structure of human cervical mucus","volume":"47","author":"Odeblad","year":"1968","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0169-409X(93)90017-X","article-title":"Cervical-mucus \u2014 problems and opportunities for drug-delivery via the vagina and cervix","volume":"11","author":"Katz","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/187221109789105658","article-title":"Mucoadhesive vaginal drug delivery systems","volume":"3","author":"Acarturk","year":"2009","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0085","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0090","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","article-title":"Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?","volume":"3","author":"das Neves","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0100","doi-asserted-by":"crossref","first-page":"138ra179","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0105","series-title":"Vaginal Delivery of Paclitaxel via Nanoparticles with Non-Mucoadhesive Surfaces Suppresses Cervical Tumor Growth","author":"Yang","year":"2013"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2012.05.006","article-title":"Unique features of antiviral immune system of the vaginal mucosa","volume":"24","author":"Kumamoto","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0897.2010.00842.x","article-title":"Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens","volume":"63","author":"Wira","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","article-title":"Innate and adaptive immunity in female genital tract: cellular responses and interactions","volume":"206","author":"Wira","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0897.2011.00970.x","article-title":"Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections","volume":"65","author":"Wira","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0135","doi-asserted-by":"crossref","first-page":"e48328","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-10-331","article-title":"Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse","volume":"10","author":"Moench","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/er.2009-0018","article-title":"Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection","volume":"31","author":"Hel","year":"2010","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2013.120","article-title":"IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0155","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.vaccine.2010.11.084","article-title":"Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen","volume":"29","author":"Arias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2012.07.039","article-title":"Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations","volume":"162","author":"Pattani","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0165","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/aid.2012.0262","article-title":"RMP-02\/MTN-006: a phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate","volume":"28","author":"Anton","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.00597-11","article-title":"Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques","volume":"56","author":"Nuttall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0175","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.biomaterials.2013.05.012","article-title":"A review of nanotechnological approaches for the prophylaxis of HIV\/AIDS","volume":"34","author":"Date","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/17425240903338055","article-title":"Nanoparticle-based vaginal drug delivery systems for HIV prevention","volume":"7","author":"Mallipeddi","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10520290500138422","article-title":"A quantitative method for assessing stages of the rat estrous cycle","volume":"80","author":"Hubscher","year":"2005","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.20021109","article-title":"Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2","volume":"197","author":"Zhao","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0195","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/JVI.77.8.4558-4565.2003","article-title":"Progesterone increases susceptibility and decreases immune responses to genital herpes infection","volume":"77","author":"Kaushic","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/aje\/kwn103","article-title":"A longitudinal study of vaginal douching and bacterial vaginosis\u2014a marginal structural modeling analysis","volume":"168","author":"Brotman","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/OLQ.0b013e318235502b","article-title":"The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk","volume":"39","author":"Gorbach","year":"2012","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0210","doi-asserted-by":"crossref","first-page":"e80074","DOI":"10.1371\/journal.pone.0080074","article-title":"Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota","volume":"8","author":"O'Hanlon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/sti.2007.026625","article-title":"Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis","volume":"84","author":"Cherpes","year":"2008","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0220","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/OLQ.0b013e3181a74924","article-title":"Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis","volume":"36","author":"Hemmerling","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/JCM.30.3.663-666.1992","article-title":"Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora","volume":"30","author":"Briselden","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.05.035","article-title":"Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1 beta","volume":"198","author":"Cauci","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0235","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ajog.2006.02.036","article-title":"Variation in vaginal immune parameters and microbial hydrolytic enzymes in bacterial vaginosis positive pregnant women with and without Mobiluncus species","volume":"195","author":"Culhane","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QCO.0b013e32835c20cd","article-title":"The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment","volume":"26","author":"Verstraelen","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0245","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1067\/mob.2000.108857","article-title":"Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle","volume":"183","author":"Patton","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0255","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/315776","article-title":"Estrogen protects against vaginal transmission of simian immunodeficiency virus","volume":"182","author":"Smith","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0260","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/JVI.79.5.3107-3116.2005","article-title":"Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation","volume":"79","author":"Gillgrass","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1089\/aid.2012.0271","article-title":"Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues","volume":"29","author":"Chandra","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0270","first-page":"619","article-title":"Proliferative changes in the genital tissue of female mice during the estrous-cycle","volume":"23","author":"Evans","year":"1990","journal-title":"Cell Tissue Kinet."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0275","first-page":"547","article-title":"Cornification of the human vaginal epithelium","volume":"90","author":"Asscher","year":"1956","journal-title":"J. Anat."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/aja.1000540103","article-title":"The structure of the human vaginal mucosa in relation to the menstrual cycle and to pregnancy","volume":"54","author":"Smith","year":"1934","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0285","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/mp400087y","article-title":"Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues","volume":"10","author":"Ensign","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI0213236","article-title":"Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent","volume":"109","author":"Khanna","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5173(85)90021-3","article-title":"Topical vaginal drug delivery in the guinea-pig. 1. Effect of estrous-cycle on the vaginal membrane-permeability of Vidarabine","volume":"24","author":"Durrani","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2008.04.038","article-title":"Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine","volume":"360","author":"Kanazawa","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","article-title":"An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection","volume":"439","author":"Palliser","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0310","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2011.02.002","article-title":"Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system","volume":"155","author":"Wu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0315","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-6-90","article-title":"Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission","volume":"6","author":"Cone","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0320","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3851\/IMP1463","article-title":"Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety","volume":"14","author":"Wilson","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0325","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1021\/bp0342553","article-title":"Transport of polymeric nanoparticle gene carriers in gastric mucus","volume":"20","author":"Dawson","year":"2004","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0330","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0335","doi-asserted-by":"crossref","first-page":"e4294","DOI":"10.1371\/journal.pone.0004294","article-title":"Altering mucus rheology to \u201csolidify\u201d human mucus at the nanoscale","volume":"4","author":"Lai","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0345","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0350","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.036","article-title":"In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery","volume":"156","author":"Cu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0355","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0360","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0365","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chom.2008.12.003","article-title":"Durable protection from herpes simplex virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene","volume":"5","author":"Wu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0370","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0375","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","article-title":"Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection","volume":"162","author":"Steinbach","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0380","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","article-title":"Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles","volume":"26","author":"Ham","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0385","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0390","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2010.10.032","article-title":"pH-sensitive Eudragit nanoparticles for mucosal drug delivery","volume":"403","author":"Yoo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0395","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2011.06.007","article-title":"Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion","volume":"44","author":"Meng","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0400","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijpharm.2012.07.070","article-title":"Chemico-physical investigation of tenofovir loaded polymeric nanoparticles","volume":"436","author":"Belletti","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0405","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00007435-200211000-00007","article-title":"Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis","volume":"29","author":"Achilles","year":"2002","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0410","doi-asserted-by":"crossref","first-page":"e61416","DOI":"10.1371\/journal.pone.0061416","article-title":"Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis","volume":"8","author":"Chaowanachan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0415","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s11095-011-0622-3","article-title":"Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine","volume":"29","author":"das Neves","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2013.08.049","article-title":"Assessing the physical\u2013chemical properties and stability of dapivirine-loaded polymeric nanoparticles","volume":"456","author":"das Neves","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0425","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp4002365","article-title":"In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine","volume":"10","author":"das Neves","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0430","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-013-1287-x","article-title":"Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice","author":"das Neves","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0435","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.antiviral.2012.09.015","article-title":"Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis","volume":"96","author":"Date","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0440","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2012.10.018","article-title":"DNA nanotherapy for pre-neoplastic cervical lesions","volume":"128","author":"Peng","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0445","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13346-011-0038-y","article-title":"Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles","volume":"1","author":"Blum","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0450","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0455","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0460","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0465","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virol.2010.06.008","article-title":"Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus macaques with RT-SHIV","volume":"405","author":"Caron","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0470","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/03639045.2011.637048","article-title":"Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention","volume":"38","author":"Wang","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"Pt 12","key":"10.1016\/j.jconrel.2014.04.033_bb0475","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1099\/0022-1317-71-12-2899","article-title":"Liposomes modulate human immunodeficiency virus infectivity","volume":"71","author":"Konopka","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0480","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1016\/j.biomaterials.2011.07.068","article-title":"Liposomes for HIV prophylaxis","volume":"32","author":"Malavia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3851\/IMP2346","article-title":"Cytolytic nanoparticles attenuate HIV-1 infectivity","volume":"18","author":"Hood","year":"2013","journal-title":"Antivir. Ther."},{"issue":"Pt 4","key":"10.1016\/j.jconrel.2014.04.033_bb0490","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1099\/0022-1317-79-4-731","article-title":"Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression","volume":"79","author":"Wachinger","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0495","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2007.10.029","article-title":"Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol","volume":"75","author":"Maher","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0500","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/jps.22529","article-title":"Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention","volume":"100","author":"Alukda","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0505","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2012.12.023","article-title":"Advancements in the field of intravaginal siRNA delivery","volume":"167","author":"Yang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0510","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0010-7824(97)00154-6","article-title":"Tests of vaginal microbicides in the mouse genital herpes model","volume":"56","author":"Zeitlin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0515","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0928-0987(99)00033-0","article-title":"Liposomes containing drugs for treatment of vaginal infections","volume":"8","author":"Pavelic","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0520","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(01)00637-8","article-title":"Liposomal gels for vaginal drug delivery","volume":"219","author":"Pavelic","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0525","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2005.03.032","article-title":"Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir","volume":"106","author":"Pavelic","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0530","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3109\/03639045.2012.707204","article-title":"Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal","volume":"39","author":"Karimunnisa","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0535","first-page":"421","article-title":"Liposomal drug delivery of metronidazole for the local treatment of vaginitis","volume":"2","author":"Patel","year":"2009","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0540","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08982104.2013.826242","article-title":"Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel","volume":"24","author":"Vanic","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0545","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/03639045.2012.670247","article-title":"Characterization of various deformable liposomes with metronidazole","volume":"39","author":"Vanic","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0550","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jps.22785","article-title":"Liposomal delivery system enhances anti-inflammatory properties of curcumin","volume":"101","author":"Basnet","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0555","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/10611861003649712","article-title":"A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel","volume":"18","author":"Kang","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0560","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","article-title":"Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications","volume":"15","author":"Menjoge","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0565","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.addr.2009.11.022","article-title":"Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV\/AIDS","volume":"62","author":"du Toit","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0570","first-page":"561","article-title":"VivaGel (SPL7013 Gel): a candidate dendrimer\u2014microbicide for the prevention of HIV and HSV infection","volume":"2","author":"Rupp","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0575","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1371\/journal.pone.0012309","article-title":"Structure activity relationship of dendrimer microbicides with dual action antiviral activity","volume":"5","author":"Tyssen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0580","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/OLQ.0b013e3181bc0aac","article-title":"Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study","volume":"37","author":"O'Loughlin","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0585","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/QAI.0b013e31823f2aeb","article-title":"Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety","volume":"59","author":"Moscicki","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 4","key":"10.1016\/j.jconrel.2014.04.033_bb0590","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/01.aids.0000390706.81383.f3","article-title":"The last decade of microbicide clinical trials in Africa: from hypothesis to facts","volume":"24","author":"Ramjee","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0595","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/mp050023q","article-title":"Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention","volume":"2","author":"McCarthy","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0600","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.3390\/molecules18077912","article-title":"Dendrimers as potential therapeutic tools in HIV inhibition","volume":"18","author":"Peng","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0605","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1128\/JVI.69.12.7383-7390.1995","article-title":"Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide\/3\u2032 sulfo-galactosyl ceramide-positive cell line","volume":"69","author":"Harouse","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0610","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/JVI.66.8.4848-4854.1992","article-title":"Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells","volume":"66","author":"Yahi","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0615","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.carbpol.2012.06.044","article-title":"Synthesis of a new amphiphilic glycodendrimer with antiviral functionality","volume":"90","author":"Han","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0620","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/bc034156a","article-title":"Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120","volume":"15","author":"Kensinger","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0625","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2010.09.004","article-title":"Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1","volume":"408","author":"Rosa Borges","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0630","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/jac\/dkh399","article-title":"Glycodendritic structures: promising new antiviral drugs","volume":"54","author":"Rojo","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0635","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.febslet.2006.03.061","article-title":"Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding","volume":"580","author":"Tabarani","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0640","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1039\/c1cc13213j","article-title":"Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cells","volume":"47","author":"Ciobanu","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0645","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jconrel.2012.04.050","article-title":"Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile","volume":"161","author":"Chonco","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0650","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.colsurfb.2012.07.011","article-title":"Complexation of HIV derived peptides with carbosilane dendrimers","volume":"101","author":"Ionov","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0655","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2008.04.002","article-title":"Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro","volume":"34","author":"Dutta","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0660","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagen.2006.12.007","article-title":"Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly(propyleneimine) dendrimer","volume":"1770","author":"Dutta","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0665","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2008.07.035","article-title":"Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes","volume":"132","author":"Weber","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0670","series-title":"Dendrimers in Anti-HIV Therapy","author":"Dzmitruk","year":"2011"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0675","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/j.biomaterials.2010.02.075","article-title":"Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer\u2013drug conjugates","volume":"31","author":"Menjoge","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0680","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2010.05.030","article-title":"Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers","volume":"395","author":"Wang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0685","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/mp200027z","article-title":"Injectable PAMAM dendrimer\u2013PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation","volume":"8","author":"Navath","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0690","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrmicro3028","article-title":"Antimicrobial activity of metals: mechanisms, molecular targets and applications","volume":"11","author":"Lemire","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0695","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3155-3-6","article-title":"Interaction of silver nanoparticles with HIV-1","volume":"3","author":"Elechiguerra","year":"2005","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-8-1","article-title":"Mode of antiviral action of silver nanoparticles against HIV-1","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0705","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-3155-8-15","article-title":"PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0710","first-page":"5007","article-title":"Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection","volume":"7","author":"Mohammed Fayaz","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0715","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/cbic.200900294","article-title":"Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells","volume":"10","author":"Martinez-Avila","year":"2009","journal-title":"Chembiochem"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0720","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1002\/chem.200900923","article-title":"Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN","volume":"15","author":"Martinez-Avila","year":"2009","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0725","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1021\/ja710321g","article-title":"Inhibition of HIV fusion with multivalent gold nanoparticles","volume":"130","author":"Bowman","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0730","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.bmcl.2010.03.079","article-title":"Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents","volume":"20","author":"Di Gianvincenzo","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0735","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1021\/nn202155y","article-title":"Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment","volume":"5","author":"Ma","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0740","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0745","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/CDLI.7.6.899-903.2000","article-title":"Calcium phosphate nanoparticle adjuvant","volume":"7","author":"He","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0750","first-page":"1021","article-title":"Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2","volume":"9","author":"He","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jconrel.2014.04.033_bb0755","doi-asserted-by":"crossref","first-page":"e51995","DOI":"10.1371\/journal.pone.0051995","article-title":"Nanoparticle transport from mouse vagina to adjacent lymph nodes","volume":"7","author":"Ballou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.04.033_bb0760","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00242-3","article-title":"Thermosensitive sol-gel reversible hydrogels","volume":"54","author":"Jeong","year":"2012","journal-title":"Advanced drug delivery reviews"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914002521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914002521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T07:31:14Z","timestamp":1597822274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914002521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":152,"alternative-id":["S0168365914002521"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.033","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-based drug delivery to the vagina: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}